"Understanding the Impact of JN.1 Variant on Rising COVID Cases"
The CDC warns that the JN.1 variant may be intensifying the spread of COVID-19, with the variant accounting for 62% of variants and rising in prevalence internationally. Despite high COVID activity, infections are causing less severe disease, possibly due to greater immune protection. Meanwhile, a study projects increased uptake of shorter, all-oral regimens for drug-resistant TB, but efforts are needed to ensure accessibility. Additionally, data from Malaysia reveals that 3.4% of Omicron survivors had long COVID at 3 months, with symptoms affecting daily activities and work. In other news, Philadelphia confirms a measles cluster, South Sudan reports a yellow fever outbreak, and a deadly attack on polio vaccination guards occurs in Pakistan.